Aruna Bio

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
Aruna Bio is the leader in the development of neural exosomes for treatment of neurodegenerative diseases. Exosomes are micro-sized vesicles released and received by nearly all cells in the body and serve as a natural cellular communication system. Aruna is utilizing its proprietary neural exosome platform and manufacturing capability to develop a pipeline of therapeutics capable of revolutionizing treatment of a range of neurodegenerative disorders and stroke. Aruna’s neural exosome platform is also being developed as a means to carry a variety of therapeutics including siRNAs, ASOs and antibodies across the blood brain barrier and into the brain and CNS.
Company Type:
Company Website:
Company HQ State:
Georgia
Company HQ Country:
United States
Year Founded:
2003
Main Therapeutic Focus:
Lead Product in Development:
AB126
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Multiple potential products and use as a drug delivery platform
Speaker
photo
Chief Executive Officer
Aruna Bio